RGDS and DGEA-induced [Ca2+]i signalling in human dermal fibroblasts  by Mineur, P. et al.
.elsevier.com/locate/bbaBiochimica et Biophysica AcRGDS and DGEA-induced [Ca2+]i signalling in human dermal fibroblasts
P. Mineur a,*,1, A. Guignandon b,1, Ch.A. Lambert a, M. Amblard c, Ch.M. Lapie`re a, B.V. Nusgens a
a Lab. Biologie des Tissus Conjonctifs, University of Lie`ge, Belgium
b Lab. Biologie du Tissu Osseux, INSERM E366, University of Saint-Etienne, France
c Lab. des Aminoacides, Peptides et Prote´ines, University of Montpellier I et II, France
Received 19 July 2004; received in revised form 18 July 2005; accepted 19 July 2005
Available online 3 August 2005Abstract
A pulse of short peptides, RGDS and DGEA in the millimolar range, immediately elicits in normal human fibroblasts a transient increase of
intracellular Ca2+ ([Ca2+]i). In the present study, we show that this [Ca
2+]i occurs in an increasing number of cells as a function of peptides
concentration. It is specific of each peptide and inhibited at saturating concentration of the peptide in the culture medium. The [Ca2+]i transient
depends on signalling pathways slightly different for DGEA and RGDS involving tyrosine kinase(s) and phosphatase(s), phospholipase C,
production of inositol-trisphosphate and release of Ca2+ from the cellular stores. GFOGER, the classical collagen binding peptide of a1- a2- and
a11-h1 integrins, in triple helical or denatured form, does not produce any Ca2+ signal. The [Ca2+]i signalling induced by RGDS and DGEA is
inhibited by antibodies against h1 integrin subunit while that mediated by RGDS is also inhibited by antibodies against the a3 integrin. Delay in
the acquisition of responsiveness is observed during cell adhesion and spreading on a coat of fibronectin for RGDS or collagen for DGEA or on a
coat of the specific integrin-inhibiting antibodies but not by seeding cells on GFOGER or laminin-5. This delay is suppressed specifically by
collagenase acting on the collagen coat or trypsin on the fibronectin coat. Our results suggest that free integrins and associated focal complexes
generate a Ca2+ signal upon recognition of DGEA and RGDS by different cellular pathways.
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The engagement of integrins with their immobilized ligands
generates a cascade of intracellular signals including activation
of kinases, release of phosphatidylinositol by phospholipases
and increased concentration of intracellular-free calcium [1,2].
The minimal recognition sequence of fibronectin and a number
of other extracellular macromolecules is RGD (Arg–Gly–Asp)
[3]. This sequence recognized by different integrins is able to
block cell adhesion to diverse adhesive proteins [4]. RGD-
containing short peptides are also known to increase cytosolic
calcium ions in various types of cells [5]. The RGD sequence is
also found in the a1 and a2 chains of type I collagen, although
under a cryptic conformation [6] and the attachment of cells to0167-4889/$ - see front matter D 2005 Elsevier B.V. All rights reserved.
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Integrins a1h1, a2h1 and a11h1 are the major cell surface
receptors of collagen type I [7–9] and recognize a distinct
binding site containing the GFOGER sequence [10–12]. A
DGEA (Asp–Gly–Glu–Ala) sequence present in the cyano-
gen bromide peptide a1CB3 of the type I collagen was
reported to bind to a2h1 integrin and to inhibit the a2h1-
mediated adhesion of platelets to collagen and that of T47D to
collagen and laminin [13] and to interfere in the a2h1
signalling in many cell types [14–19]. DGEA is also able to
induce Ca2+ transients in the human osteoblastic SaOS-2 line
[20,21]. RGD and DGEA are also present in cell surface
proteins such as L1CAM that can associate through these
sequences in cis with the h1 integrin subunit. CHL1, a murine
close homolog to L1, was recently shown to modulate neuronal
cell migration and other integrin-dependent functions through
these sequences [22,23].
In this work, we used RGDS and DGEA in the millimolar
range to trigger an immediate rise of intracellular calcium in
human fibroblasts. This [Ca2+] transient of short durationta 1746 (2005) 28 – 37
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phosphoinositide pathway triggered by protein kinase(s) and
phospholipase(s). The goal of this study was to better
understand the mechanism used by the cells to perceive the
signal carried by the peptides and the implication of integrins in
the process.
2. Materials and methods
2.1. Reagents
RGDS, AAAA, bradykinin, ionomycin, calyculin A, LaCl3, EGTA,
BAPTA-AM, thapsigargin, herbimycin A, genistein, neomycin, poly-l-lysine,
and bovine serum albumin were purchased from Sigma (St Louis, MI),
xestospongin C, okadaic acid, PP2 and U73343 from Calbiochem (San Diego,
CA), U73122 from ICN (Costa Mesa, CA), PP1 from Alexis Corporation
(Lausen, Switzerland), trypsin from Life Technologies Inc. (Rockville, MD)
and highly purified bacterial collagenase from Advance Biofactures Corpora-
tion (Lynbrook, NY). DGEAwas from Research Genetics (Huntsville, AL) and
KGDS from Bachem AG (Bubendorf, Switzerland). (GPO)nGFOGER(GPO)n
was a generous gift of M. Hook, Houston, Texas [11]. Function blocking
monoclonal antibodies anti-human integrin subunits a1 (clone FB12), a2
(clone P1E6), a4 (clone P4G9) and a6 (clone GoH3) were from Chemicon
(Temecula, CA), a3 (clone P1B5) and rabbit anti-mouse IgG from DAKO
(Carpinteria, CA), a5 (clone P1D6) and h1 (clone P4C10) from Life
Technologies Inc. Anti-human av (clone 17E6) is a generous gift from S. L.
Goodman [24]. Fetal calf serum and DMEM were from Life Technologies Inc.,
Fluo3-AM from Molecular Probes (Eugene, OR), borosilicate coverslip Lab-
TekR from Falcon (Becton Dickinson, Franklin Lakes, NJ). Type I collagen
was purified from bovine skin as described by Delvoye et al. [25] and
fibronectin was purified from human plasma as described by Hayashi and
Yamada [26]. Laminin-5 was kindly offered by M. Aumailley (Dpt.
Biochemistry II, University of Koeln, Germany).
2.2. Cell culture
Normal human skin fibroblasts were grown from skin biopsies of a young
healthy donor by the explant procedure described earlier [25] and used between
passages 8 and 13. Human rhabdomyosarcoma RD cells were purchased from
Biowhittaker (Walkersville, MD). All cells were mycoplasma-free and
routinely cultured in DMEM in the presence of 10% fetal calf serum (FCS),
2 mM glutamine, penicillin–streptomycin (100 IU/ml each) and ascorbic acid
(50 Ag/ml) (=standard medium) at 37 -C in a humidified atmosphere containing
5% CO2.
2.3. Fluo3-AM loading and fluorescence recording
For routine experiments, cells were plated in borosilicate culture chambers
(Lab-TekR) for 18 h in DMEM-10% FCS, rinsed with serum-free medium and
incubated with the fluorophore Fluo3-AM (10 AM) in serum-free medium for 1
h. In short term adhesion experiments (up to 150 min), the trypsinized cells
were plated in serum-free medium and the Fluo3-AM added for the last 20 min.
After loading, cells were washed and immediately tested in serum-free medium.
The observation of the fluorescence emitted by the Fluo3-labeled cells started 5
min after the last washing. Microscope fields taken at random in the culture
were examined by a confocal microscope (Meridian, Akemos, MI). At a
magnification of 63 the microscope field contained 5–12 cells. The Fluo3-
loaded cells were excited by an Argon LASER at 488 nm and the emitted
fluorescence recorded at 530 nm in each cell of the field and in real time. Image
processing and data computing were performed using the Meridian software.
The intensity of the emitted fluorescence was recorded every second during at
least 100 s. As the overall fluorescence intensity varied from cell to cell, the
level of fluorescence of each cell at the beginning of the recording was
normalised to one arbitrary unit. The baseline of resting cells spontaneously
oscillated by T5% around the level of the first image acquisition. A 10% rise
above the baseline was considered as a significant calcium rise and the cellregarded as responsive. The results were expressed as the percentage of
responding cells.
2.4. Stimulation by the peptides
After a 20 s period of baseline recording, 10 Al of a solution in water or in
phosphate-buffered saline (PBS) of the various peptides (DGEA, AAAA,
RGDS, KGDS) of the indicated amount (in nanomoles) was gently added on
top of the cells under microscopic examination. Ten Al of an aqueous solution
of bradykinin (2 nmol) was similarly injected before completion of the
recording to test the ability of the examined cell population to produce a [Ca2+]i
rise. The peptide GFOGER in triple helical conformation by renaturation at 4
-C overnight or denatured by heating at 70 -C 10 min. was similarly tested
using an amount of 10 nmol.
2.5. Coating of culture surfaces
When indicated borosilicate culture chambers (Lab-TekR) were coated
with fibronectin (30 Ag/ml in PBS), native type I collagen (20 Ag/ml in PBS),
poly-l-lysine (100 Ag/ml) or monoclonal anti-integrin subunits h1 (10 Ag/ml),
a3 (10 Ag/ml) or a5 (10 Ag/ml). One ml of solutions was used per square
centimeter. The fibronectin solution was incubated for 1 h at room temperature.
The unoccupied reactive sites were blocked with 0.2% heat denatured bovine
serum albumin (BSA), washed with PBS at room temperature and dried.
Monomeric collagen coats were prepared by drying the collagen solution at
4 -C, washing and drying at room temperature. Poly-l-lysine solution was
adsorbed overnight at 4 -C. Laminin-5 was coated overnight at 4 -C, blocked
with 1% heat denatured BSA for 1 h at room temperature and washed with
PBS. All the coated slides were stored at 4 -C. The anti-integrin coated surface
were prepared as described by Schwartz [1]. The borosilicate slides were
coated first with 50 Ag/ml by rabbit anti-mouse IgG for 1 h at 37 -C, washed
with PBS, blocked with 1% heat denatured BSA, washed again, incubated for
1 h with 10 Ag/ml of the specific monoclonal antibodies (anti-h1, anti-a3 or
anti-a5 integrins) in 1% heat denatured BSA, rinsed with PBS and
immediately used. Coating with the GFOGER peptides was obtained by
incubating the slides overnight at 4 -C with a 1 mM solution in phosphate-
buffered saline (PBS) of the triple helical peptide, washed in PBS and blocked
with 1% heat-denatured BSA. All reactions and testing were performed at
maximum 25 -C.
2.6. Enzymatic digestion of coated substrates
Fibroblasts were plated in serum-free medium on fibronectin and native
type I collagen coated coverslips for 60 min and loaded with Fluo3-AM (10
AM) during the last 20 min. After washing with PBS, the cultures were
incubated for 3 min at 25 -C with trypsin (10 Ag/ml) in DMEM or with highly
purified bacterial collagenase (50 U/ml) in 0.05 M Tris, 0.15 M NaCl, 2 mM
CaCl2 pH 7.5 before adding the peptide agonist DGEA or RGDS and recording
the fluorescence.
2.7. Pharmacological investigations
The following pharmacological investigations were performed on fibro-
blasts plated on glass for 18 h before Fluo3-AM loading. Genistein (10 AM),
thapsigargin (2 AM), BAPTA-AM (30 AM) neomycin (10 AM) were added 3
h before loading, PP1 and PP2 (20 AM) were added 90 min before use,
herbymicin A (10 AM), xestospongin C (20 AM), calyculin A (500 pM) and
okadaic acid (10AM) at the time of loading, EGTA (2 mM), La3+ (80 AM),
U73122 and U73343 (1 AM) just before fluorescence analysis. Anti-h1 and anti-
a-integrins subunit monoclonal antibodies were added at a final concentration of
10 Ag/ml of culture medium 30 min before testing the effect of the peptides.
2.8. Cytotoxicity assays
The cytotoxicity of the various agents used in this study was tested by
measuring the activity of the mitochondrial succinate dehydrogenase [27] as
previously described [28].
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Comparisons between groups were based on parameters using the one-way
analysis of variance (ANOVA). When the ANOVA test was significant, the
Tukey–Kramer multiple comparisons test was used to compare the groups
versus control.
3. Results
3.1. DGEA and RGDS induce an intracellular free calcium
[Ca2+]i transient in fibroblasts
Single-cell, real-time fluorescence recording was per-
formed by confocal microscopy on human skin fibroblasts
attached for 18 h to glass coverslips in Lab-TekR chambers
and loaded with Fluo3-AM. Typically, the fluorescence in
resting fibroblasts was diffuse within the cytoplasm withFig. 1. Time-course variation (in s) of the fluorescence in glass-plated fibroblasts tre
and (D) RGDS (10 nmol). Fluo3-AM loaded cells were treated with the various pep
fluorescence intensity of the individual cells was normalised to 1 at the beginningscattered spots of higher intensity and accentuated in the
perinuclear area (not illustrated). The variability in fluores-
cence intensity before normalisation to 1.0 was between 1000
and 2000 fluorescence units for a scale of 0 to 4095. The
subcellular localisation of the fluorescence in resting cells
remained similar for the total duration of data acquisition (at
least 100 s) while the overall fluorescence intensity only
slightly decreased with time (Fig. 1A), likely due to
bleaching. The compartmentalization of the dye was sup-
pressed by ionomycin (1 AM) that produced an uniform
fluorescent signal in the cell. The calculated mean intracel-
lular free calcium concentration ([Ca2+]i) was 120T30 nM, a
value in close agreement to that reported in the literature
[29]. To assess the ability of the cells to respond by a rise in
[Ca2+]i, the fibroblasts were always stimulated with bradyki-
nin (2 nmol) at the end of each experiment. It induced a riseated with (A) AAAA (10 nmol), (B) bradykinin (2 nmol), (C) DGEA (10 nmol)
tides at the indicated time (arrow) during the recording of the fluorescence. The
of the recording.
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A similar burst of fluorescence was observed in fibroblasts
excited by 10 nmol DGEA or RGDS in water or phosphate-
buffered saline. The recording of fluorescence intensity as a
function of time in the individual cells of the microscope
field is illustrated in Fig. 1. No significant increase of the
fluorescence was induced by AAAA (Fig. 1A) or by the
solvents alone (not shown). Bradykinin induced a rise of
fluorescence in every cell within a few seconds (Fig. 1B) and
its intensity peaked at 150 to 200% of the initial value before
slowly and progressively returning to the baseline. A similar
increased fluorescence was induced by DGEA (Fig. 1C)
within T10 s to reach a peak at T150% and a rapid return to
the baseline value. RGDS also rapidly induced a significant
rise (T130%) of fluorescence followed by a slower decline to
the baseline values (Fig. 1D) while KGDS, at the same
concentration, had no effect (not shown). Prolonged acqui-
sition of data up to 5 min failed to detect cells responding
later by a significant peak. The peptide-induced Ca2+ rise
could be repeated several times. To assess that the peak of
fluorescence was actually due to an increased [Ca2+]i, the
cells were loaded with the membrane-permeant calcium
chelator BAPTA-AM for 3 h prior to addition of the
peptides. This resulted in a total suppression of the Ca2+
transients in response to the active peptides (Table 1). The
peak of fluorescence induced by both peptides was similar in
the fibroblasts attached for 18 h on a glass support uncoated
or coated with monomeric collagen, fibronectin, laminin-5 or
poly-l-lysine.
The calcium response of the human dermal skin fibroblasts
was further analyzed by varying the concentration of DGEA
and RGDS. The number of responsive cells increased accord-
ing to a semi-log dose–response relationship (Fig. 2) up to a
maximum of 90% of the cell population upon stimulation by 10
nmol of peptide, the half-maximal response being observed atTable 1
Effect of inhibition of various signalling pathways on the [Ca2+]i transients induced
plated on glass for 18 h
Agents Target Percentage of ce
DGEA
None 89T7
BAPTA-AM Intracellular Ca2+ 0*
EGTA Extracellular Ca2+ 90T9
La3+ Plasma membrane Ca2+ channels 96T6
Thapsigargin ER Ca2+-ATPase 0*
Xestospongin C IP3-mediated Ca
2+ Release 22T32*
Genistein Tyrosine kinases 0T0*
Herbimycin A Tyrosine kinases 70T23
PP1 Src tyrosine kinases 100T0
PP2 Src tyrosine kinases 100T0
Okadaic acid Phosphatases 94T5
Calyculin A Phosphatases 1 and 2A 100T0
Neomycin Phospholipase C 6T7*
U73122 Phospholipase C 6T10*
U73343 Inactive analog of U73122 95T7
ER Ca2+-ATPase: endoplasmic reticulum Ca2+-ATPase; IP3: Inositol (1, 4, 5) trisph
* P <0.001 versus control sample.0.1 nmol. By contrast, the size of the fluorescence peak, i.e.,
the increase in intracellular Ca2+ in the responding cells, was
independent of the concentration of the stimulating peptide. A
pulse of 10 nmol of peptide was selected for the following
experiments.
The peptide GFOGER, the known collagen I binding site of
the a1-, a2- and a11-h1 integrins, in the triple helical
configuration or denatured, added at the same amount (10
nmol) did not induce any Ca2+ transient. This addition did not
interfere with the production of the [Ca2+]i transient produced
by DGEA or RGDS or the [Ca2+]i signal produced by
bradykinin.
3.2. DGEA- and RGDS-induced [Ca2+]i transients involve
calcium mobilization from internal stores by a slightly different
mechanism
The origin of the calcium ions participating in the [Ca2+]
transient in response to both DGEA and RGDS peptides was
investigated by using a variety of agents known to interfere
with calcium movements (Table 1). Addition of EGTA to
chelate calcium in the extracellular space or of La3+ ions,
known to block the plasma membrane calcium channels, 10
min prior to addition of DGEA, RGDS or bradykinin, did not
affect the calcium responses. Treatment of the cells for 3 h with
thapsigargin, an inhibitor of the endoplasmic reticulum
ATPases-dependent calcium pump [30], suppressed the
[Ca2+]i transients induced by both peptides and by bradykinin.
Xestospongin C, known as an inhibitor of inositol-trispho-
sphate (IP3) receptor [31], reduced the DGEA- and RGDS-
induced signals. These data indicate that the rise in [Ca2+]i
induced by DGEA and RGDS depends upon an IP3-mediated
mobilization of the ion from the internal stores and not by a
significant influx of the ion from the extracellular space.
Xestospongin C did not inhibit the [Ca2+]i transient induced byby DGEA (10 nmol), RGDS (10 nmol) and bradykinin (2 nmol) in fibroblasts
lls responding to Number of cells/experiments
RGDS Bradykinin after DGEA RGDS
DGEA RGDS
90T7 97T5 100 97/10 115/10
0* 0 0 16/2 12/2
87T11 100 100 30/3 17/3
72T13 100 100 26/3 27/3
0* 0 0 18/2 16/2
15T21* 100 100 17/2 18/2
5T7* 100 90T0 16/2 20/2
20T13* 100 100 60/8 19/2
82T16 92T12 100 22/2 24/2
80T28 100 96T6 21/2 22/2
15T19* 100 98T4 35/3 56/4
17T15* 100 100 22/3 29/3
11T10* 8T1 0 36/5 27/3
3T5* 0 0 24/3 24/3
80T18 100 100 21/2 25/2
osphate.
Fig. 2. Dose–response relationship of glass-plated fibroblasts to DGEA (0),
RGDS (r), AAAA () and solvent alone (10 Al) (). The calcium signal was
monitored as described in Materials and methods on a total of 22 to 38 cells in 4
separate experiments. The percentage (TSD) of responding cells is plotted
against the amount of added peptide or solvent alone.
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inhibition is related to the short half-life of xestospongin C
after replacing the medium before pulsing with the peptides
[32].
To further analyze the signalling triggered by DGEA,
RGDS and bradykinin, cells were treated with a panel of
agents known to inhibit different pathways originating from
membrane receptors. Genistein, a broad spectrum inhibitor of
tyrosine kinases, abrogated the cell response to both peptides
while herbimycin A, but not PP1 and PP2, inhibitors more
selective of the src-family tyrosine kinases, strongly reduced
the effect of RGDS and barely affected the response to DGEA.
Calyculin A and okadaic acid, phosphatases 1 and 2A
inhibitors, reduced the activity of RGDS but not that of
DGEA. No effect was observed with tyrphostin A23, an
inhibitor of growth factor receptor tyrosine kinase activity (data
not shown). The PLC inhibitors, U73122 but not its inactive
analog (U73343) and neomycin, extensively reduced the Ca2+
signalling by both DGEA and RGDS as well as by bradykinin.
The toxicity of the inhibitors was tested by the MTT test asTable 2
Effects of DGEA, RGDS and soluble anti-integrins antibodies on the [Ca2+]i transie
fibroblasts plated on glass for 18 h
Treatment Percentage of cells responding to
DGEA RGDS
None 84T4 89T2
DGEA (1 mM) 33T11* 95T6
RGDS (1 mM) 88T6 48T8*
Anti-h1 21T6* 8T13*
Anti-a1, -a2, -a4, -a5 74T12 86T9
Anti-a3 90T9 0T0*
Anti-a1, -a2, -a3, -a4, -a5 100T0 13T9*
Anti-a6 74T1 100T0
Anti-av 100T0 94T9
* P <0.001 versus control sample.previously described [28]. All were devoid of toxicity at the
concentrations and for the delay of application used here
except BAPTA-AM, that reduced the mitochondrial activity of
50% after 6 h.
3.3. RGDS and DGEA target different binding molecules
To assess whether DGEA and RGDS target different
receptors, DGEA- and RGDS-induced calcium responses were
analyzed in cells incubated with high concentration (1 mM) of
the peptides added in the medium 30 min before the assay. Cells
maintained in 1 mM DGEA fully responded to RGDS and
bradykinin while the response elicited by DGEA dropped to
35% (Table 2). Conversely, cells maintained in 1 mM RGDS
fully responded to DGEA and bradykinin while the proportion
of RGDS-responding cells decreased to 50%. These results
suggest that distinct membrane receptors are used by each of the
peptides.
To assess the role of integrins in the peptide-induced
calcium transients, fibroblasts plated on glass in presence of
10% FCS for 18 h were treated with function blocking
monoclonal antibodies against human a1, a2, a3, a4, a5,
a6, av and h1 integrin subunits (10 Ag/ml), alone or in
combination, 30 min prior to challenging with the peptides.
The anti-h1 integrin antibodies blocked the Ca2+ transients
induced by both DGEA and RGDS (Table 2). Irrelevant
monoclonal anti-mouse IgG or heat-denatured bovine serum
albumin, used at the same concentration, did not affect the
calcium signals. Blocking anti-a1, -a2, -a4, -a5, -a6 and -av
subunit integrin monoclonal antibodies, alone or in combina-
tion, were unable to inhibit the response to RGDS while it was
completely suppressed by anti-a3 subunit antibodies, alone or
in combination with the four other anti-a subunits. None of
these seven anti-a subunit antibodies, alone or in combination,
was able to block the response to DGEA. Addition of
bradykinin induced a rise of [Ca2+]i in more than 95% of the
cells after treatment with each of the antibodies, alone or
combined. The inhibitory activity of anti-h1 towards RGDS
and DGEA and of anti-a3 towards RGDS was similar in cells
plated on coated matrices, collagen or fibronectin or poly-l-
lysine (not illustrated).nts induced by DGEA (10 nmol), RGDS (10 nmol)and bradykinin (2 nmol)in
Number of cells/experiments
Bradykinin after DGEA RGDS
DGEA RGDS
100 100 39/3 35/3
100 100 24/2 25/2
100 96T6 25/2 25/2
100 100 28/3 28/3
100 100 43/3 38/3
98T3 98T3 56/4 57/4
100 96T6 22/2 23/3
100 100 19/2 15/2
100 100 25/2 22/2
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transiently and specifically represses the [Ca2+]i response to,
respectively, RGDS and DGEA, while laminin-5 has no effect
Fibroblasts were seeded on native monomeric type I collagen,
fibronectin, laminin-5 or poly-l-lysine and the peptide-induced
calcium signalling was analyzed as a function of time after
plating. The first observation was performed 45 min after
seeding. When plated on collagen, fibronectin or laminin-5, the
cells rapidly attached and progressively spread after 150 min
(not shown), while on poly-l-lysine the fibroblasts were rapidlyFig. 3. Modulation of the calcium response to DGEA and RGDS by the substrate. Ce
loaded with Fluo3-AM during the last 20 min preceeding the stimulation by the pe
recorded at increasing time after plating starting at 45 min on a total of 17 to 52 ce
differences versus the values at 150 min are *P <0.05, **P <0.01 and ***P <0.00immobilized but remained rounded. On native type I collagen,
the number of cells displaying a [Ca2+]i response to RGDS was
maximal at all tested times (Fig. 3A) while the reactivity to
DGEA was very low at 45 min and progressively increased to
reach maximal values at 100–120 min. Conversely, on
fibronectin the RGDS-induced [Ca2+]i signalling was low at
45min and progressively increasedwith time up to 150min (Fig.
3B). A significantly reduced reactivity to DGEA was also
observed in this condition during the first 60 min. No lag period
was noted for both peptides in cells plated on poly-l-lysine (Fig.
3C) or on laminin-5 (not shown). When the fibroblasts werells plated on (A) native type I collagen, (B) fibronectin or (C) poly-l-lysine were
ptides. The percentage of responding cells to DGEA () and RGDS (r) was
lls in 3 to 4 separate experiments for each time point. The significance of the
1 by the Tukey–Kramer test.
Fig. 4. Effect of enzymatic digestion of the substrates on the calcium response
to DGEA and RGDS during the refractory period. Fibroblasts were plated on
native type I collagen or fibronectin for 60 min and loaded with Fluo3-AM
during the last 25 min. After washing, the cultures were treated with trypsin o
bacterial collagenase for 5 min at room temperature and the calcium response to
RGDS or DGEA was monitored on a total of 27 to 41 cells in 3 differen
experiments for each condition. g no enzyme treatment; ˝ collagenase;
trypsin. *P <0.01, enzyme treated versus control.
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observed upon stimulation by DGEA, RGDS or bradykinin. The
[Ca2+]i signal in response to bradykinin was close to 100% at all
time points tested on each of the substrates (not shown). These
results suggest that the recognition site specific to each peptide is
temporarily unavailable during cell adhesion.
To further assess the role of the extracellular support, cells
plated for 60 min, i.e., in the middle of the refractory period, on
type I collagen or on fibronectin were treated either with highly
purified bacterial collagenase or trypsin, washed and stimulated
within 5 min by DGEA or RGDS. More than 50% of the cells
seeded on collagen and treated with collagenase became
responsive to DGEA (Fig. 4) while most cells in the untreated
cultures or incubated with trypsin failed to respond. RGDS and
bradykinin induced the expected positive response (not
illustrated). Conversely, treating the cultures on a fibronectin
coat by trypsin restored a significant response to RGDS (Fig. 4)
while collagenase treatment was uneffective. DGEA and
bradykinin induced the expected strong response (not illustrat-
ed). These observations suggest that the signalling complex for
the peptides is made available by specific proteolysis of the
coated proteins during the period of spreading.
To further ascertain the role of integrin-based transduction
of the peptides signalling, cells were seeded on coats of anti-
h1, a3 and a5 antibodies. On a coat of anti-h1 integrin bound
to anti-mouse IgG, the cells attached and the [Ca2+]i signal
induced by both DGEA and RGDS was reduced at 60 min, and
remained low at 150 min, i.e., beyond the period of non-
responsiveness on ECM coats, to reach a full responsiveness
only after 240 min. (Table 3). When anti-a3 integrin was used
as a coat the lag period only concerned the [Ca2+] signal
triggered by RGDS. Cells seeded on a coat of anti-a5 subunit
fully responded with no delay to both peptides. The [Ca2+]i
signalling by bradykinin was not affected at any time under any
of the experimental conditions.
4. Discussion
In this study, short synthetic peptides contained in the
sequence of extracellular matrix proteins were used to induce
intracellular [Ca2+] transients in normal human fibroblasts.
Addition of DGEA or RGDS in the millimolar range to
attached normal human fibroblasts rapidly triggered a short-
lived rise in intracellular [Ca2+] shown by an increased
fluorescence of Fluo3. It was most visible in and around the
nucleus as reported in other types of cells [33]. This
distribution agrees with the description of the perinuclear
location of agonist-stimulated elementary Ca2+ signals acting
as initiator of calcium movements [34] and the release of
nuclear and perinuclear Ca2+ by mechanical stress [35], an
integrin mediated process. RGD-containing proteins or pep-
tides are known to trigger [Ca2+] signals in a number of cell
types among which endothelial cells [36], fibroblasts [37],
osteoclasts [33,38], epithelial cells [39], smooth muscle cells
[40] and lymphocytes [41]. DGEA has been less investigated.
It was shown to induce [Ca2+] transients in the osteoblast-like
cell line SaOS-2 [20,21]. Here, we show that fibroblastsrespond to RGDS as well as to DGEA but not to GFOGER
by calcium transients. These cells reacted to the active
peptides by a concentration-dependent number of responsive
cells up to a maximum of 90% and a lack of relationship
between the amount of added peptide and the level of
fluorescence. Such an all-or-none effect might depend on two
different mechanisms, the all or none reaction and the graded
response [42]. Additional work is needed to answer this
question. The reason why some cells are unresponsive to the
peptides while they are all responsive to bradykinin is not
clear. It is not related to the basal level of fluorescence, i.e.,
the intracellular concentration of calcium and/or the amount
of loaded fluorescent indicator, neither to the cell cycle state
since mitomycin-growth arrested fibroblasts were similarly
responsive (data not shown). Cell attached to poly-l-lysine
that remain rounded also produced a signal of a size similar
to that observed in spread cells.
While the [Ca2+] rise induced by DGEA rapidly returned to
the baseline values, the signals induced by RGDS were more
persistent suggesting that the peptides target different receptors
or trigger different signalling pathways. This is further supported
by the positive response to one peptide in the presence of a
saturating concentration of the other, the non-responsiveness to
the peptides during adhesion only on a specific support, distinct
effects of some inhibitors of the signalling pathways and the
sensitivity to specific anti-integrin antibodies.
In our experimental model, [Ca2+]i mobilization by RGDS
or DGEA did not require calcium entry from the extracellular
medium since La3+ or EGTA in the culture medium did not
affect the response. This independence on extracellular calcium
has already been observed in fibroblasts [43]. It is in sharp
contrast with data published for osteoblast-like cells [21]. The
difference may be explained by the low number of calcium
channels in the human fibroblasts. By using a panel of
pharmacological agents at non-toxic concentrations [28], we
suggest that the calcium mobilized by DGEA and RGDS
originates from intracellular stores and requires tyrosine-
kinase(s), the release of phosphoinositides by phospholipase
C and opening of the IP3-sensitive calcium channels of ther
t
Table 3
[Ca2+]i induced by DGEA (10 nmol) and RGDS (10 nmol) in fibroblasts plated
on coated subunit integrin monoclonal antibodies
Percentage of responding cells Number of cells/
experiments
DGEA RGDS Bradykinin(2 nmol) after DGEA RGDS
DGEA RGDS
Anti-a5
60 min 89T6 93T10 100 100 29/2 28/2
150 min 85T11 100T0 100 100 23/2 30/2
240 min 92T11 100T0 100 100 31/2 23/2
Anti-b1
60 min 32T27* 31T17* 100 100 26/3 51/4
150 min 17T10** 32T33* 95T6 100 38/3 26/3
240 min 96T6 80T2 100 100 21/2 25/2
Anti-a3
60 min 87T3 34T16* 95T7 95T6 38/4 61/5
150 min 68T11 91T5 100 94T1 30/2 32/2
240 min 96T6 75T15 100 100 21/2 27/2
* P <0.05.
** P <0.01 versus the anti-a5 samples.
P. Mineur et al. / Biochimica et Biophysica Acta 1746 (2005) 28–37 35intracellular stores. Furthermore, a phosphatase activity seems
required for RGDS signalling as suggested by suppression of
the Ca2+ signal by okadaic acid and calyculin A. Several
kinases are found in vicinity of the cytoplasmic tail of the
integrins in the focal adhesions, including FAK125 and
members of the src family [44]. The broad spectrum inhibitor
genistein suppresses the Ca2+ signalling of both peptides. The
greater sensitivity of the RGDS-induced [Ca2+]i signalling to
herbimycin A suggests a role of one or several defined
members of these kinases family in the RGDS- but not in the
DGEA-induced signalling. The src-kinases do not seem to be
involved since the more specific inhibitors PP1 and PP2 are
inactive. The proposed pathways are partly similar to those
used in signalling by growth factor receptors and integrins [45].
Interactions between cells and the extracellular matrix are
regulated by small GTPases of the Rho family. These Rho
GTPases are key signalling molecules regulating the architec-
ture of the cytoskeleton [46] and the assembly of proteins into
focal adhesions [47]. In preliminary experiments, RhoA, Rac1
and Cdc42 were knocked-down by the si-RNA technology that
we previously described [48]. Si-Rac1 extensively repressed
the Ca2+ signal-induced by RGDS while the signal produced
by DGEA was not affected by any of these siRNAs (personal
unpublished results). As opposed to DGEA, RGDS is a
recognized ligand for a large family of integrins [4], among
which a3h1. Our data support a classical signalling for RGDS
but do not exclude an alternate mechanism as discussed later.
Using blocking antibodies indicated that a3h1 is involved
in the RGDS-induced [Ca2+]i transient. The integrin a3h1 is
very versatile and involved in adhesion, migration and
signalling and may negatively cooperate with a2h1 [49].
Although the preferential ligand of a3h1 integrin has been
identified as laminin-5 [50], this integrin may function as a
subsidiary receptor of broad specificity. It can also bind to
collagens and fibronectin [7], entactin [51] and thrombospon-din [52]. Recently, Akula et al. [53] demonstrated that the
human herpes virus-8 (HHV-8) interacts with a3h1 integrin by
an RGD sequence. In our study, the absence of lag period in
fibroblasts plated on laminin-5 during adhesion indicates that
the signalling complex is directly available on that support as
opposed to what is observed when the cells are plated on
fibronectin, a more physiological support.
Activation of integrins leads to a mobilization of intracellular
calcium, an ubiquitous cell signalling involved in adhesion,
migration and many other functions including gene expression
and apoptosis [54]. In our fibroblasts, suppression of the DGEA-
induced [Ca2+] rise by monoclonal antibodies suggests the
involvement of integrin(s) of the h1 family in the process. The
blocking antibodies against the a1 and a2 integrin subunit failed
to suppress the response to DGEA suggesting that neither the
integrin a1h1 nor a2h1 is the transducing receptor. A similar
observation was made in the SaOS-2 cells treated with a panel of
different monoclonal anti-a2 antibodies which also failed to
block the DGEA-induced [Ca2+] transients [20]. Furthermore,
the efficient induction of [Ca2+] signalling by DGEA in
rhabdomyosarcoma cells (personal results) which lack the a2
integrin [55] supports the existence of another pathway for the
reception of the message. Antibodies against the a3, a4, a5, a6
and av integrin subunits, alone or in combination, also failed to
inhibit the [Ca2+] signalling induced by DGEA. The a11h1
integrin also recognize type I collagen [9]. The lack of function
blocking antibodies for a11 precluded testing its participation in
the peptide-induced Ca2+ signalling at the present time.
GFOGER is the recognized ligand of the integrin a1-, a2- and
a11-I domain [56,12]. As this peptide GFOGER in triple helical
or denatured form does not induce a Ca2+ transient, an
alternative recognition site on the h1 integrins has to be
considered for the Ca2+ signalling induced by DGEA.
The existence of a non-classical receptive site for DGEA on
(a) h1 integrin (s) can be postulated on the basis of the
observations of Buhusi et al. [22]. Indeed, the haptotactic
migration of neuronal and glial cells is potentiated by CHL1, a
close homolog of the L1 cell adhesion molecules associated
with a1h1 and a2h1 integrins. This stimulation is suppressed
by mutation of the DGEA motif of CHL1 suggesting therefore
the existence of a receptor site in cis on h1 integrins. CHL1 has
not been detected in murine fibroblasts using the antibody
offered by Schachner [22] (unpublished information). Other
membrane proteins might display the same role. A mechanism
similar to that suggested for DGEA could also apply for RGDS.
Indeed, the L1CAM operates in neural cells a function similar to
CHL1 and contains an intrinsic RGD sequence critical for
promoting migration on fibronectin [23]. An operational
mechanism can be hypothetized on the basis of the above
mentioned observations. Further work is planned to identify
these integrins-associated proteins and their participation in the
regulation of Ca2+ signalling induced by DGEA and RGDS.
The lack of responsiveness towards the peptides during
adhesion and spreading on collagen for DGEA and fibronectin
for RGDS may coincide with the ligand-specific recruitment of
the integrins and the associated protein(s) [57]. A similar lag
period during spreading was observed in fibroblasts plated on
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RGDS and anti-h1 for DGEA). These observations are
complemented by the recovery of responsiveness during
spreading by specific proteolysis of the substrate, collagenase
suppressing the lag period of DGEA on the collagen coat while
trypsin does the same to RGDS on fibronectin. Degradation of
the substrate is indeed known to allow some integrins to be freed
from their ligand and recycle to the cell surface [58]. The
hypothesis that the integrins are not available for signalling
during adhesion and spreading has been further considered. As
observed by immunostaining and confocal microscopy using
anti-h1 antibody, the distribution of these integrins is very
similar during the lag period at 45 min of attachment and at 150
min when the cells are fully spread and reactive. On fibronectin,
but to some extent also on collagen, the h1 integrins are more
clustered along the spreading membrane at 45 min but also
present on both the ventral and dorsal faces of the cells. At 150
min, they are more evenly distributed on the total surface, ventral
and dorsal. As seen by Western blotting, the sub-cellular
distribution (detergent soluble and insoluble fractions) of h1
integrins and vinculin are similar whatever the coat (collagen,
fibronectin or poly-l-lysine) and the time after seeding (data not
shown). It demonstrates that the availability of the h1 integrins
and their associated focal adhesions does not explain the lag
period related to spreading. This observation is, however, of
limited significance since all h1 integrins might not behave
similarly. The absence of lag period for DGEA in cells seeded on
GFOGER, the known integrin recognition site of native
collagen, needs further investigations. Although this peptide in
triple helical configuration is a recognized ligand of a1- a2- and
a11h1 integrins, and allows attachment and spreading of the
fibroblasts, it does not however represent the only recognition
site of these integrins for collagen [11].
RGDS and DGEA, two peptides contained in the sequence
of extracellular matrix proteins and their breakdown products,
trigger in fibroblasts a calcium transient by acting on two
different integrins of the h1 family. The calcium is released
from intracellular stores by a similar pathway using tyrosine
kinase(s), PLC and IP3 for both peptides and requires
phosphatase activity for RGDS alone. The present work adds
support to the participation of a non classical recognition of the
peptides by h1 integrins.
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